Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Agudelo NM"'
Autor:
Fletcher, HA, Filali-Mouhim, A, Nemes, E, Hawkridge, A, Keyser, A, Njikan, S, Hatherill, M, Scriba, TJ, Abel, B, Kagina, BM, Veldsman, A, Agudelo, NM, Kaplan, G, Hussey, GD, Sekaly, R-P, Hanekom, WA, BCG study team, McShane, H
Publikováno v:
BMC Medicine
Background An incomplete understanding of the immunological mechanisms underlying protection against tuberculosis (TB) hampers the development of new vaccines against TB. We aimed to define host correlates of prospective risk of TB disease following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a7c55ad23fcf920e6605e348b0776a
https://ora.ox.ac.uk/objects/uuid:ca024b02-1d1b-4e0b-a9d7-f935669fe3a7
https://ora.ox.ac.uk/objects/uuid:ca024b02-1d1b-4e0b-a9d7-f935669fe3a7
Autor:
Fletcher HA; London School of Hygiene & Tropical Medicine, London, UK., Filali-Mouhim A; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Nemes E; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Hawkridge A; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Keyser A; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Njikan S; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Abel B; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Kagina BM; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Veldsman A; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Agudelo NM; Grupo de Inmunología Celular e Inmunogenética, Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia., Kaplan G; Public Health Research Institute, Rutgers Biomedical and Health Sciences, Newark, NJ, USA., Hussey GD; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Hanekom WA; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. willem.hanekom@gatesfoundation.org.
Publikováno v:
BMC medicine [BMC Med] 2016 May 16; Vol. 14, pp. 76. Date of Electronic Publication: 2016 May 16.
